Cornerstone Investment Partners LLC boosted its holdings in McKesson Corporation (NYSE:MCK – Free Report) by 0.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 98,004 shares of the company’s stock after acquiring an additional 585 shares during the quarter. McKesson comprises about 3.2% of Cornerstone Investment Partners LLC’s investment portfolio, making the stock its 14th biggest holding. Cornerstone Investment Partners LLC owned 0.08% of McKesson worth $75,712,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Leuthold Group LLC raised its holdings in shares of McKesson by 3.5% in the 3rd quarter. Leuthold Group LLC now owns 15,998 shares of the company’s stock worth $12,359,000 after purchasing an additional 545 shares in the last quarter. Savvy Advisors Inc. grew its position in McKesson by 37.6% in the third quarter. Savvy Advisors Inc. now owns 571 shares of the company’s stock worth $441,000 after buying an additional 156 shares during the last quarter. Plan A Wealth LLC increased its holdings in shares of McKesson by 4.7% in the third quarter. Plan A Wealth LLC now owns 688 shares of the company’s stock valued at $532,000 after buying an additional 31 shares in the last quarter. Cibc World Market Inc. lifted its position in shares of McKesson by 28.1% during the 3rd quarter. Cibc World Market Inc. now owns 24,243 shares of the company’s stock valued at $18,729,000 after acquiring an additional 5,318 shares during the last quarter. Finally, Caprock Group LLC bought a new stake in shares of McKesson during the 3rd quarter worth $6,034,000. Institutional investors own 85.07% of the company’s stock.
Insiders Place Their Bets
In related news, EVP Thomas L. Rodgers sold 276 shares of McKesson stock in a transaction on Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the sale, the executive vice president owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. The trade was a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction on Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. 0.08% of the stock is currently owned by company insiders.
McKesson Stock Up 1.8%
McKesson (NYSE:MCK – Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. During the same quarter last year, the firm earned $8.03 earnings per share. The business’s revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities research analysts expect that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.
McKesson Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. McKesson’s dividend payout ratio is 9.43%.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on MCK. Morgan Stanley reaffirmed an “overweight” rating and set a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th. Zacks Research cut McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 25th. Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. Finally, Barclays began coverage on shares of McKesson in a report on Monday, December 8th. They set an “overweight” rating and a $960.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $937.07.
View Our Latest Stock Report on MCK
About McKesson
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Read More
- Five stocks we like better than McKesson
- Trump’s Hand-Written Letter Will Shock his Haters
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
